Alzheimer’s drug Leqembi has full FDA approval

Name: Alzheimer’s drug Leqembi has full FDA approval
Uploaded: 2023-07-07T21:16:29Z
Duration: 2 min 33 s
Description: U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease. The Food and Drug Administration decision clears the way for Medicare and other insurers to begin paying for the drug called Leqembi.

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease. The Food and Drug Administration decision clears the way for Medicare and other insurers to begin paying for the drug called Leqembi.

Posted July 7, 2023 5:16pm EDT